Blackrock Neuroport Array

Implantable microelectrode array by Blackrock Neurotech for recording and stimulating brain activity, used in clinical brain-computer interface applications for patients with paralysis and neurological disorders

Yes. Blackrock Neuroport Array is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Blackrock Neuroport Array is made by Blackrock Neurotech, based in Salt Lake City, Utah, USA, founded in 2008.

5 verified deployments of Blackrock Neuroport Array are on the DEPLOY registry, including at Houston, Texas, USA, Davis, California, USA, Atlanta, Georgia, USA.

Blackrock Neuroport Array is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable biometric robots to Blackrock Neuroport Array include BrainQ Non-Invasive BCI, Neko Body Scan, RNS System, Amazfit (Balance / Active / T-Rex / Helio).

Blackrock Neuroport Array and BrainQ Non-Invasive BCI (BrainQ · 3 deployments) are both biometric robots on the DEPLOY registry. Blackrock Neuroport Array has 5 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Blackrock Neuroport Array ranks in roughly the top under 1% of biometric models tracked by the registry.

Blackrock Neuroport Array is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Blackrock Neuroport Array has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.